Trials Set for Eli Lilly's Five Obesity Compounds

Tolchin, Elizabeth
June 2004
Drug Discovery & Development;Jun2004, Vol. 7 Issue 6, p22
Provides information on the clinical trial candidates of Eli Lilly & Co. in Indianapolis for treatment of obesity. Development of the drugs by the company; Efficacy of the drugs; Use of animal models for testing the drugs; Aim for the drugs.


Related Articles

  • COMPANY SPOTLIGHT-- Eli Lilly and Company.  // PharmaWatch: CNS;August 2004, Vol. 3 Issue 8, p19 

    The article presents information on Eli Lilly and Company's plans to disclose the results of all clinical trials for which it is a sponsor. The Indianapolis-based group will place all the data on a publicly available registry. The registry will include results of all phase I through phase IV...

  • Evidence-based assessment of key points for decision-makers: obesity.  // European Health Report 2005;2005, p36 

    The article highlights the evidence-based assessment of key points for decision-makers in obesity-related problems. According to the author, the risks related to obesity can be reduced through weight reduction. Moreover, the risks associated with obesity, even if weight reduction is not...

  • Effects of Ear Points' Pressing on Parameters Related to Obesity in Non-Obese Healthy and Obese Volunteers. Ching-Hui Yeh; Shu-Chuan Jennifer Yeh // Journal of Alternative & Complementary Medicine;Apr2008, Vol. 14 Issue 3, p309 

    Objectives: The aim of this study was to evaluate the effects of ear points' pressing at ear meridian points on the following obesity-related parameters: body weight; body fat; body–mass index; waist; hip circumference (HC); and waist circumference (WC)/HC ratio between two groups of...

  • A proposed protocol for the development of a register of trials of weight management of childhood overweight and obesity. Steinbeck, K. S.; Baur, L. A.; Morris, A. M.; Ghersi, D. // International Journal of Obesity;Jan2006, Vol. 30 Issue 1, p2 

    Introduction: Currently, there is no international co-ordinated approach to research into childhood obesity. This is despite much research activity in this area and the universality of the condition.Method: This proposal involves the development of an international...

  • COMPANY SPOTLIGHT--Eli Lilly and Company.  // PharmaWatch: Monthly Review;August 2004, Vol. 3 Issue 8, p36 

    Indianapolis, Indiana-based Eli Lilly and Co. recently announced plans to disclose the results of all clinical trials for which it is a sponsor. The company will place all the data on a publicly available registry. The move comes in response to revelations that drug companies hide negative...

  • Lilly slaps Times over trials data charge. M. A. // Medical Marketing & Media;Mar2008, Vol. 43 Issue 3, p32 

    The article reports that pharmaceutical company, Lilly, has responded with a raised voice to the "New York Times," article accusing Lilly suppressing Prozac clinical trials data. The company has explained that the allegation is not true, since the clinical trial results are publicly available...

  • Lilly lymphoma drug designated orphan status.  // PharmaWatch: Cancer;May2007, Vol. 6 Issue 5, p4 

    The article reports that pharmaceutical company Eli Lily and Co. has revealed that the European Medicines Agency has granted its investigational cancer agent enzastaurin orphan drug designation for the treatment of diffuse large B-cell lymphoma (DLBCL). The trial is a study in DLBCL patients at...

  • Successful Weight Maintainers: Recovery from Relapse.  // Eating Disorders Review;Mar/Apr2004, Vol. 15 Issue 2, p7 

    Discusses the findings of the United States-based National Weight Control Registry on the effective means for obesity treatment. Research works of the National Weight Control Registry; Importance of helping patients to avoid lapses in weight maintenance; Recommendations to health professionals...

  • Cures for Fat People.  // Electronic Ardell Wellness Report (E-AWR);8/12/2005, Issue 296, p1 

    This article presents various suggestions for the treatment of obese people. Biomedical researchers at the University of Missouri-Columbia Frank Booth and Simon Lees, predict that all Americans will be obese by 2044 and 2058, respectively, if the current progressive rise in the rate of obesity...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics